ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

Zhang, Xin; Zhang, Xingda; Li, Guozheng; Hao, Yi; Liu, Lei; Zhang, Lei; Chen, Yihai; Wu, Jiale; Wang, Xinheng; Yang, Shuai; Xu, Shouping*哈尔滨医科大学
Journal of Immunology Research2022-5-5DOI: 10.1155/2022/3143511
8被引9阅读
引用收藏
分享

摘要

Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between necroptosis-associated lncRNAs and BRCA. In this study, we established a signature basis of 7 necroptosis-related lncRNAs associated with prognosis and divided BRCA patients into high- and low-risk groups. Kaplan-Meier curves all showed an adverse prognosis for patients in the high-risk group. Cox assays confirmed that risk score was an independent prognostic factor for BRCA patients. The receiver operating characteristic (ROC) curve proved the predictive accuracy of the signature and the area under the curve (AUC) values of the risk score reached 0.722. The nomogram relatively accurately predicted the prognosis of the patients. GSEA analysis suggested that the related signaling pathways and biological processes enriched in the high- and low-risk groups may influence the tumor microenvironment (TME) of BRCA. ssGSEA showed the difference in immune cell infiltration, immune pathway activation, and immune checkpoint expression between the two risk groups, with the low-risk group more suitable for immunotherapy. According to the significant difference in IC50 between risk groups, patients can be guided for an individualized treatment plan. Overall, the authors established a prognostic signature consisting of 7 necroptosis-associated lncRNAs that can independently predict the clinical outcome of BRCA patients. The difference in the tumor immune microenvironment between the low- and high-risk populations may be the reason for the resistance to immunotherapy in some patients.

学科与关键词

关键词
CELL-DEATHEXPRESSIONAPOPTOSISPYROPTOSISCROSSTALKRECEPTORPROMOTESINVASIONNECROSISPATHWAY
相关
加载中…
  • Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
    Jiang, Zi-Rong; Yang, Lin-Hui; Jin, Liang-Zi; Yi, Li-Mu; Bing, Ping-Ping; Zhou, Jun*; Yang, Jia-Sheng*Frontiers in Oncology, 2022, 12: 988680.被引 25
  • A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
    Luo, Jian; Peng, Jiayu; Xiao, Wanying; Huang, Shujing; Cao, Yanqing; Wang, Ting; Wang, Xicheng*Frontiers in Genetics, 2022, 13: 984696.
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2022-05-05
卷期
第 2022 卷
页码
3143511
DOI
10.1155/2022/3143511
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81602323, 81872149]

作者

  • Z

    Zhang, Xin (第一作者)

  • Z

    Zhang, Xingda

查看全部 11 位作者收起作者
  • L

    Li, Guozheng

    harbin med univ

  • H

    Hao, Yi

    harbin med univ

  • L

    Liu, Lei

    harbin med univ

  • Z

    Zhang, Lei

    harbin med univ

  • C

    Chen, Yihai

    harbin med univ

  • W

    Wu, Jiale

    harbin med univ

  • W

    Wang, Xinheng

    harbin med univ

  • Y

    Yang, Shuai

    harbin med univ

  • X

    Xu, Shouping (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417